ArticleJournal of diabetes investigation2016

Effective treatment with combination of peripheral 5-hydroxytryptamine synthetic inhibitor and 5-hydroxytryptamine 2 receptor antagonist on glucocorticoid-induced whole-body insulin resistance with hyperglycemia.

Shaoxin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.